Nicox S.A. (ALCOX.PA)

EUR 0.22

(-4.48%)

Operating Income Summary of Nicox S.A.

  • Nicox S.A.'s latest annual operating income in 2023 was -17.5 Million EUR , up 41.9% from previous year.
  • Nicox S.A.'s latest quarterly operating income in 2023 FY was -19.78 Million EUR , up 41.9% from previous quarter.
  • Nicox S.A. reported an annual operating income of -34.06 Million EUR in 2022, up 25.97% from previous year.
  • Nicox S.A. reported an annual operating income of -46.01 Million EUR in 2021, down -580.62% from previous year.
  • Nicox S.A. reported a quarterly operating income of -19.78 Million EUR for 2023 FY, up 41.9% from previous quarter.
  • Nicox S.A. reported a quarterly operating income of -4121.50 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Nicox S.A. (2023 - 2019)

Historical Annual Operating Income of Nicox S.A. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -17.5 Million EUR 41.9%
2022 -34.06 Million EUR 25.97%
2021 -46.01 Million EUR -580.62%
2020 -6.76 Million EUR 63.12%
2019 -18.33 Million EUR 0.0%

Peer Operating Income Comparison of Nicox S.A.

Name Operating Income Operating Income Difference
European Medical Solutions -135 Thousand EUR -12865.185%
FERMENTALG -11.8 Million EUR -48.23%
argenx SE -417.15 Million EUR 95.804%
BioSenic S.A. -7.04 Million EUR -148.622%
Celyad Oncology SA -8.45 Million EUR -106.965%
Hyloris Pharmaceuticals SA -15.99 Million EUR -9.442%
Onward Medical N.V. -35.46 Million EUR 50.644%
Oxurion NV -12.11 Million EUR -44.533%
PHAXIAM Therapeutics S.A. -23.66 Million EUR 26.023%
Financière de Tubize SA -2.14 Million EUR -716.381%
UCB SA 604 Million EUR 102.898%